Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IDECABTAGENE VICLEUCEL vs ILOPROST: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IDECABTAGENE VICLEUCEL vs ILOPROST: Safety Overview

Metric IDECABTAGENE VICLEUCEL ILOPROST
Total FAERS Reports 1,037 4,961
Deaths Reported 137 2,277
Death Rate 13.2% 45.9%
Hospitalizations 356 2,324
Average Patient Age 65.3 yrs 57.9 yrs
% Female Patients 41.9% 70.7%
FDA Approval Date N/A Aug 7, 2009
Manufacturer Celgene Corporation BTG International Inc
Route INTRAVENOUS INTRAVENOUS
Marketing Status N/A Discontinued